Application of pbk as a target of cisplatin resistance in ovarian cancer

A technology of ovarian cancer and cisplatin, which is applied in the field of anti-ovarian cancer drugs, can solve problems such as unseen research on the relationship, and achieve the effect of improving the treatment effect

Active Publication Date: 2021-08-27
SHANDONG UNIV QILU HOSPITAL
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the relationship between PBK and ovarian cancer development and cisplatin resistance has not been studied

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of pbk as a target of cisplatin resistance in ovarian cancer
  • Application of pbk as a target of cisplatin resistance in ovarian cancer
  • Application of pbk as a target of cisplatin resistance in ovarian cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0033] It should be noted that the following detailed description is exemplary and intended to provide further explanation of the present disclosure. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs.

[0034] It should be noted that the terminology used herein is only for describing specific embodiments, and is not intended to limit the exemplary embodiments according to the present disclosure. As used herein, unless the context clearly dictates otherwise, the singular is intended to include the plural, and it should also be understood that when the terms "comprising" and / or "comprising" are used in this specification, they mean There are features, steps, operations, means, components and / or combinations thereof.

[0035] Explanation of terms:

[0036] PBK detection reagents: including the reagents needed to detect PBK content by common de...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The disclosure belongs to the field of anti-ovarian cancer drugs, and specifically relates to the application of PDZ-binding kinase as a cisplatin-resistant target of ovarian cancer. In the prior art, there is no research on the relationship between PDZ kinase and ovarian cancer, and the relationship between the mechanism of cisplatin resistance. In order to clarify the mechanism of cisplatin resistance in ovarian cancer patients and provide better therapeutic drugs for ovarian cancer patients, this disclosure conducts research on the expression level of PBK and cisplatin resistance in ovarian patients. Further studies have shown that PBK overexpression promotes autophagy in ovarian cancer cells, and by promoting autophagy, ovarian cancer cells develop drug resistance to cisplatin. In the present disclosure, the combination of PBK inhibitor and cisplatin is used to treat ovarian cancer, and the therapeutic effect is better than that of cisplatin alone.

Description

technical field [0001] The disclosure belongs to the field of anti-ovarian cancer drugs, and specifically relates to the application of PBK as a cisplatin resistance marker of ovarian cancer and the combined use of PBK inhibitors and cisplatin in treating ovarian cancer. Background technique [0002] The information disclosed in this Background section is only intended to increase the understanding of the general background of the disclosure, and is not necessarily to be taken as an acknowledgment or any form of suggestion that the information constitutes prior art that is already known to those skilled in the art. [0003] Malignant ovarian tumor is one of the common malignant tumors of female reproductive organs. The onset of ovarian cancer is hidden. Most patients are diagnosed at an advanced stage, and the five-year survival rate is only about 30%. The annual statistical report of the American Cancer Society shows that in 2019, there will be 22,530 new cases of ovarian c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K45/00A61P35/00A61K33/243C12Q1/6886
CPCA61K33/24A61K45/00A61P35/00C12Q1/6886C12Q2600/106C12Q2600/118C12Q2600/158A61K2300/00
Inventor 孔北华马汉林苑存忠
Owner SHANDONG UNIV QILU HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap